€4.48
7.18% yesterday
Xetra, Jun 30, 05:36 pm CET
ISIN
DE000A0BL849
Symbol
V3V
Index
Sector
Industry

Vita 34 Stock price

€4.48
+0.36 8.74% 1M
+0.36 8.74% 6M
+0.36 8.74% YTD
+0.08 1.82% 1Y
-6.07 57.54% 3Y
-8.47 65.41% 5Y
-0.86 16.10% 10Y
-8.12 64.44% 20Y
Xetra, Closing price Mon, Jun 30 2025
+0.30 7.18%
ISIN
DE000A0BL849
Symbol
V3V
Index
Sector
Industry

Key metrics

Basic
Market capitalization
€72.9m
Enterprise Value
€72.4m
Net debt
positive
Cash
€19.2m
Shares outstanding
17.4m
Valuation (TTM | estimate)
P/E
29.86 | -
P/S
0.90 | 0.87
EV/Sales
0.90 | 0.87
EV/FCF
8.06
P/B
3.00
Dividends
DPS
€0.00
Yield 1Y | 5Y
0.00% | 0.28%
Growth 1Y | 5Y
- | -100.00%
Payout 1Y | 3Y
0.00% | 0.00%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€80.6m | €82.0m
EBITDA
€8.2m | €8.1m
EBIT
€-579.0k
Net Income
€2.6m | -
Free Cash Flow
€9.0m
Growth (TTM | estimate)
Revenue
7.72% | 6.41%
EBITDA
160.71% | 700.00%
EBIT
97.38%
Net Income
110.37% | -
Free Cash Flow
732.39%
Margin (TTM | estimate)
Gross
36.66%
EBITDA
10.20% | 9.88%
EBIT
-0.72%
Net
3.20% | -
Free Cash Flow
11.13%
Financial Health
Equity Ratio
14.88%
Return on Equity
-7.92%
ROCE
-0.54%
ROIC
-13.51%
Debt/Equity
0.77
More
EPS
€0.14
FCF per Share
€0.51
Short interest
-
Employees
783.00
Rev per Employee
€100.00k
Show more

Is Vita 34 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

Vita 34 Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Vita 34 forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Vita 34 forecast:

Buy
80%
Hold
20%

Financial data from Vita 34

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
81 81
8% 8%
100%
- Direct Costs 51 51
20% 20%
63%
30 30
177% 177%
37%
- Selling and Administrative Expenses 33 33
2% 2%
41%
- Research and Development Expense - -
-
-
8.22 8.22
161% 161%
10%
- Depreciation and Amortization 8.80 8.80
2% 2%
11%
EBIT (Operating Income) EBIT -0.58 -0.58
97% 97%
-1%
Net Profit 2.58 2.58
110% 110%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Vita 34 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells. The firm collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.

Head office Germany
CEO Jakub Baran
Employees 783
Founded 1997
Website www.famicord.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today